TGFA has been reported to accelerate cell proliferation, invasion and EMT in breast cancer, prostate cancer and hepatic cancer (39–41) and modulate lung cancer EMT through regulation by PHD3 (42). This evidence concerns the gene EGLN3 and prostate cancer.